PER 1.28% 7.9¢ percheron therapeutics limited

$36.8m raise, page-78

  1. 4,683 Posts.
    lightbulb Created with Sketch. 1086
    I still don’t discount a Sarepta partnership for FDA route.

    I can’t imagine Sarepta will pump $500m into more Gene Therapy investments / partnerships…

    You would think both Sarepta and Pfizer would be taking notice of the proteomics data ANP released.

    The message is: the P2B results were not a fluke - and the science behind the MoA is solid.

    Who will blink first?
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
0.001(1.28%)
Mkt cap ! $71.22M
Open High Low Value Volume
7.8¢ 7.9¢ 7.8¢ $1.359K 17.36K

Buyers (Bids)

No. Vol. Price($)
3 84867 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 127102 3
View Market Depth
Last trade - 10.20am 23/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.